Stockreport

Sarepta up 5% premarket on COVID-19 plan [Seeking Alpha]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF Sarepta Therapeutics (NASDAQ:SRPTenteredPursuant to the CRADA, Sarepta will design, synthesize, manufacture and provide multiple peptide-conjugated PMO constructs based [Read more]